Blood cancer discovery

Journal Details

Blood cancer discovery

Blood cancer discovery

ISSN : 26433230

P-ISSN : 26433249

CiteScore : 13.00

Impact Factor : 11.5

5 year IF : N/A

Collection : Emerging Sources Citation Index

Open Acess : NO

Acceptance rate : N/A

Publishing Model : N/A

Article Processing Charge : N/A

First Response : N/A

First post-review decision : N/A

Submission to Acceptance : N/A

Acceptance to publication : N/A

PUBLICATION TYPE : Journals

COUNTRY : Country United States

Publisher :NLM (Medline)

publisher Address : 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404

H-Index : 25

Coverage : 2020-2023

Homepage

Contact :

Issues Per Year : 6

Frequency : Bi-monthly

Transparent Peer Review : NO

Min Pages : 0

Max Pages : 0

Subject Area and Category

  • Biochemistry, Genetics and Molecular Biology
    • Biochemistry, Genetics and Molecular Biology (miscellaneous)
    • Cancer Research
  • Medicine
    • Hematology
    • Oncology

About Journal

Blood Cancer Discovery publishes high-quality Research Articles and Briefs representing major advances in basic, translational, and clinical research of leukemia, lymphoma, myeloma, and associated diseases. The topics appropriate for coverage include but are not limited to the following: molecular and cellular features of pathogenesis, therapy response and relapse, transcriptional circuits, stem cells, differentiation, microenvironment, metabolism, immunity, mutagenesis, and clonal evolution. These subjects are characterized in animal disease models as well as in high-dimensional clinical data landscapes. The journal welcomes submissions on new pharmacological, biological, and living cell therapies; new diagnostic tools; prognostic, diagnostic, and pharmacodynamic biomarkers; and computational and machine learning approaches to personalized medicine, from preclinical proof of concept to clinical trials and real-world evidence. As a forum for diverse ideas shaping future research directions, the journal will publish Reviews, Perspectives, and Commentaries on topics of broad interest in hematooncology.

Quartiles

2023
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1
Cancer Research
Q1
Hematology
Q1
Oncology
Q1

Documents per Year

Citations per Year

Comments

You need to login to add a comment.